EP0571549A4 - NOUVELLE SPECIFICITE DE L'INTEGRINE POUR LA PROTEINE Tat DE L'HIV. - Google Patents

NOUVELLE SPECIFICITE DE L'INTEGRINE POUR LA PROTEINE Tat DE L'HIV.

Info

Publication number: EP0571549A4
Authority: EP; European Patent Office
Prior art keywords: tat protein; hiv tat; novel integrin; integrin specificity; specificity
Prior art date: 1991-02-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP92907398A

Other languages

German (de)

English (en)

Other versions

EP0571549A1 (fr

Inventor

Erkki I Ruoslahti

Bruce E Vogel

Flossie Y Wong-Staal

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

University of California

Sanford Burnham Prebys Medical Discovery Institute

Original Assignee

University of California

Sanford Burnham Prebys Medical Discovery Institute

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-02-14

Filing date

1992-02-13

Publication date

1995-03-15

1992-02-13 Application filed by University of California, Sanford Burnham Prebys Medical Discovery Institute filed Critical University of California

1993-12-01 Publication of EP0571549A1 publication Critical patent/EP0571549A1/fr

1995-03-15 Publication of EP0571549A4 publication Critical patent/EP0571549A4/fr

Status Withdrawn legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70546—Integrin superfamily
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
- C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Virology (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Communicable Diseases (AREA)
Cell Biology (AREA)
Toxicology (AREA)
Zoology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

EP92907398A 1991-02-14 1992-02-13 NOUVELLE SPECIFICITE DE L'INTEGRINE POUR LA PROTEINE Tat DE L'HIV. Withdrawn EP0571549A4 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US65642491A	1991-02-14	1991-02-14
US656424		1991-02-14

Publications (2)

Publication Number	Publication Date
EP0571549A1 EP0571549A1 (fr)	1993-12-01
EP0571549A4 true EP0571549A4 (fr)	1995-03-15

Family

ID=24632975

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP92907398A Withdrawn EP0571549A4 (fr)	1991-02-14	1992-02-13	NOUVELLE SPECIFICITE DE L'INTEGRINE POUR LA PROTEINE Tat DE L'HIV.

Country Status (5)

Country	Link
EP (1)	EP0571549A4 (fr)
JP (1)	JPH06508603A (fr)
AU (1)	AU1449792A (fr)
CA (1)	CA2101919A1 (fr)
WO (1)	WO1992014755A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0522081A4 (en) *	1990-03-30	1993-06-16	Smithkline Beecham Corporation	Inhibition of disease associated with immunodeficiency virus infection
US6258550B1 (en)	1993-04-23	2001-07-10	Virginia Commonwealth University	Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
FR2731355B1 (fr) *	1995-03-08	1997-05-30	Neovacs	Nouveaux immunogenes, nouveaux anticorps, procede de preparation et compositions pharmaceutiques les renfermant
PL322143A1 (en) *	1995-03-08	1998-01-05	Neovacs	Non-topxic immunogenes originating frommretroviral regulator protein, antibodies as such, method of preparing them and pharmaceutic compositions containing them
US6200575B1 (en)	1996-03-07	2001-03-13	Neovacs	Non-toxic immunogens derived from a retroviral regulatory protein antibodies preparation process and pharmaceutical compositions comprising them
US5891994A (en) *	1997-07-11	1999-04-06	Thymon L.L.C.	Methods and compositions for impairing multiplication of HIV-1
US6399067B1 (en)	2000-04-28	2002-06-04	Thymon L.L.C.	Methods and compositions for impairing multiplication of HIV-1
WO2006088740A2 (fr)	2005-02-15	2006-08-24	Thymon, L.L.C.	Methodes et compositions permettant d'alterer la multiplication de vih-1
EP3247807B1 (fr)	2015-01-20	2020-12-16	Adcure Biotechnologies, LLC.	Variants d'adénovirus déciblés et procédés associés
US9982276B2 (en)	2015-03-12	2018-05-29	Adcure Biotechnologies, Llc.	Penton-mutated, integrin-retargeted adenovirus vectors with reduced toxicity and their use

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1989012461A1 (fr) *	1988-06-16	1989-12-28	St. Louis University	Antagonistes de proteines de transactivation virales

1992
- 1992-02-13 CA CA002101919A patent/CA2101919A1/fr not_active Abandoned
- 1992-02-13 JP JP4507307A patent/JPH06508603A/ja active Pending
- 1992-02-13 AU AU14497/92A patent/AU1449792A/en not_active Abandoned
- 1992-02-13 WO PCT/US1992/001227 patent/WO1992014755A1/fr not_active Application Discontinuation
- 1992-02-13 EP EP92907398A patent/EP0571549A4/fr not_active Withdrawn

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1989012461A1 (fr) *	1988-06-16	1989-12-28	St. Louis University	Antagonistes de proteines de transactivation virales

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BRAKE, D.A. ET AL.;: "Characterization of murine monoclonal antibodies to the tat protein from human immunodeficiency virus type 1", JOURNAL OF VIROLOGY, vol. 64, no. 2, February 1990 (1990-02-01), pages 962 - 965 *
See also references of WO9214755A1 *

Also Published As

Publication number	Publication date
WO1992014755A1 (fr)	1992-09-03
CA2101919A1 (fr)	1992-08-15
JPH06508603A (ja)	1994-09-29
EP0571549A1 (fr)	1993-12-01
AU1449792A (en)	1992-09-15

Publication	Publication Date	Title
AR244753A1 (es)	1993-11-30	Azocolorantes.
FI915736A0 (fi)	1991-12-05	A-oxoacetamidderivat.
BR7400523U (pt)	1994-11-29	Recipiente empilhável aperfeiçoado.
TR28710A (tr)	1997-01-27	Demleme paketcigi.
FR2686008B1 (fr)	1995-08-18	Moulin a condiment.
EP0630630A3 (fr)	1995-04-19	Sous-vêtement à jeter.
DE69103987D1 (de)	1994-10-20	Wiederverwertbare verpackung.
DE69111595D1 (en)	1995-08-31	Squarylium- und crokonyliumfarbstoffe.
FI903334A0 (fi)	1990-07-02	A/d- eller d/a-omvandlare, a/d- eller d/a-omvandlarsystem samt kalibreringsfoerfarande foer dessa.
NO911721D0 (no)	1991-05-02	Reaksjonsbeholder.
EP0649734A3 (fr)	1996-02-07	Emballage.
DE59300061D1 (de)	1995-03-02	Sackmaschine.
EP0571549A4 (fr)	1995-03-15	NOUVELLE SPECIFICITE DE L'INTEGRINE POUR LA PROTEINE Tat DE L'HIV.
DE68909540D1 (de)	1993-11-04	Warenausgabevorrichtung.
FR2698773B3 (fr)	1994-10-28	Paille pour boire.
ZA919371B (en)	1993-05-27	Containers.
ZA929762B (en)	1993-06-18	Novel thiazoles.
ZA93432B (en)	1993-09-13	Improved packaging element.
EP0681480A4 (fr)	1997-06-25	Vaccins a base de recognine.
ZA926675B (en)	1993-03-09	Novel herbicides.
IT209987Z2 (it)	1988-11-14	Agenda a fogli databili.
DE69012806D1 (de)	1994-10-27	Aerosolbehälter.
FR2657252B3 (fr)	1992-04-24	Tetine a fente indechirable pour biberon.
ES1023777Y (es)	1994-03-01	Bolsa mejorada.
ZA935766B (en)	1994-03-08	A folder.

Legal Events

Date	Code	Title	Description
1993-10-15	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
1993-12-01	17P	Request for examination filed	Effective date: 19930913
1993-12-01	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE
1994-06-01	RIN1	Information on inventor provided before grant (corrected)	Inventor name: WONG-STAAL, FLOSSIE, Y. Inventor name: VOGEL, BRUCE, E. Inventor name: RUOSLAHTI, ERKKI, I.
1995-03-08	RHK1	Main classification (correction)	Ipc: C12N 15/12
1995-03-15	A4	Supplementary search report drawn up and despatched
1995-03-15	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE
1995-10-17	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
1995-12-06	18D	Application deemed to be withdrawn	Effective date: 19950401